<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD11260000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P20231</UniProt_ID>
  <Seq_Length>275</Seq_Length>
  <Molecule_Weight>30515</Molecule_Weight>
  <KEGG_ID>hsa:64499</KEGG_ID>
  <Orthology_ID>K01340</Orthology_ID>
  <Function_Summary>Tryptase is the major neutral protease present in mast cells and is secreted upon the coupled activation-degranulation response of this cell type. Has an immunoprotective role during bacterial infection. Required to efficiently combat K.pneumoniae infection (By similarity).</Function_Summary>
  <Catalytic_Mechanism>Preferential cleavage: Arg-|-Xaa, Lys-|-Xaa, but with more restricted specificity than trypsin.</Catalytic_Mechanism>
  <Pfam_ID>PF00089:Trypsin</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>1</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Tryptase-2</Alias>
      <Alias>Tryptase II</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).</Detail>
      <Keyword>Serine-type peptidase activity</Keyword>
      <Ontology_ID>GO:0008236</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).</Detail>
      <Keyword>Serine-type endopeptidase activity</Keyword>
      <Ontology_ID>GO:0004252</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.</Detail>
      <Keyword>Peptidase activity</Keyword>
      <Ontology_ID>GO:0008233</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.</Detail>
      <Keyword>Proteolysis</Keyword>
      <Ontology_ID>GO:0006508</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>97</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MLNLLLLALPVLASRAYAAPAPGQALQRVGIVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVNVSSHVHTVTLPPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYVPKKP</Protein_Seq>
    <DNA_Seq>ATAAATGGGGAGGGGAGAGCCCACTGGGTAGAAGGAACAGGGAGCGGCCAGGATGCTGAATCTGCTGCTGCTGGCGCTGCCCGTCCTGGCGAGCCGCGCCTACGCGGCCCCTGCCCCAGGCCAGGCCCTGCAGCGAGTGGGCATCGTCGGGGGTCAGGAGGCCCCCAGGAGCAAGTGGCCCTGGCAGGTGAGCCTGAGAGTCCACGGCCCATACTGGATGCACTTCTGCGGGGGCTCCCTCATCCACCCCCAGTGGGTGCTGACCGCAGCGCACTGCGTGGGACCGGACGTCAAGGATCTGGCCGCCCTCAGGGTGCAACTGCGGGAGCAGCACCTCTACTACCAGGACCAGCTGCTGCCGGTCAGCAGGATCATCGTGCACCCACAGTTCTACACCGCCCAGATCGGAGCGGACATCGCCCTGCTGGAGCTGGAGGAGCCGGTGAACGTCTCCAGCCACGTCCACACGGTCACCCTGCCCCCTGCCTCAGAGACCTTCCCCCCGGGGATGCCGTGCTGGGTCACTGGCTGGGGCGATGTGGACAATGATGAGCGCCTCCCACCGCCATTTCCTCTGAAGCAGGTGAAGGTCCCCATAATGGAAAACCACATTTGTGACGCAAAATACCACCTTGGCGCCTACACGGGAGACGACGTCCGCATCGTCCGTGACGACATGCTGTGTGCCGGGAACACCCGGAGGGACTCATGCCAGGGCGACTCCGGAGGGCCCCTGGTGTGCAAGGTGAATGGCACCTGGCTGCAGGCGGGCGTGGTCAGCTGGGGCGAGGGCTGTGCCCAGCCCAACCGGCCTGGCATCTACACCCGTGTCACCTACTACTTGGACTGGATCCACCACTATGTCCCCAAAAAGCCGTGAGTCAGGCCTGGGTTGGCCACCTGGGTCACTGGAGGACCAACCCCTGCTGTCCAAAACACCACTGCTTCCTACCCAGGTGGCGACTGCCCCCCACACCTTCCCTGCCCCGTCCTGAGTGCCCCTTCCTGTCCTAAGCCCCCTGCTCTCTTCTGAGCCCCTTCCCCTGTCCTGAGGACCCTTCCCTATCCTGAGCCCCCTTCCCTGTCCTAAGCCTGACGCCTGCACCGGGCCCTCCAGCCCTCCCCTGCCCAGATAGCTGGTGGTGGGCGCTAATCCTCCTGAGTGCTGGACCTCATTAAAGTGCATGGAAATCA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Others</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular region</CellLocal>
      <Ontology_ID>GO:0005576</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Secreted</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>TPSB2</Gene_Name>
    <Gene_Alias>TPS2</Gene_Alias>
    <Gene_ID>64499</Gene_ID>
    <Genbank_ACCN>NM_003294</Genbank_ACCN>
    <Protein_ACCN>NP_003285</Protein_ACCN>
    <HGNC_ID>14120</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/7177</Gene_URL>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Asthma</Disease_Name>
      <Disease_Detail>Asthma</Disease_Detail>
      <Disease_DB>AST005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/asthma?search=TPSB2#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Human beta-tryptase II with inhibitor CRA-29382</PDB_Title>
      <PDB_ID>2FS8</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2FS8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure-guided design of Peptide-based tryptase inhibitors.</PubMed_Title>
      <Author>McGrath, M.E., et al.</Author>
      <Journal>Biochemistry(2006)45:5964-5973</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16681368?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of human tryptase with potent non-peptide inhibitor</PDB_Title>
      <PDB_ID>2ZA5</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2ZA5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Potent, nonpeptide inhibitors of human mast cell tryptase. Synthesis and biological evaluation of novel spirocyclic piperidine amide derivatives</PubMed_Title>
      <Author>Costanzo, M.J., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2008)18:2114-2121</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18272363?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>human beta-tryptase II complexed with 4-piperidinebutyrate to make acylenzyme</PDB_Title>
      <PDB_ID>2FWW</PDB_ID>
      <Resolution>2.25</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2FWW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure-guided design of Peptide-based tryptase inhibitors.</PubMed_Title>
      <Author>McGrath, M.E., et al.</Author>
      <Journal>Biochemistry(2006)45:5964-5973</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16681368?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN BETA-II TRYPTASE IN COMPLEX WITH 4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE</PDB_Title>
      <PDB_ID>2BM2</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2BM2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure Based Design of 4-(3-Aminomethylphenyl) Piperidinyl-1-Amides: Novel, Potent, Selective, and Orally Bioavailable Inhibitors of Bii Tryptase</PubMed_Title>
      <Author>Levell, J., et al.</Author>
      <Journal>Bioorg.Med.Chem.(2005)13:2859</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15781396?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human beta II tryptase with inhibitor CRA-27592</PDB_Title>
      <PDB_ID>2GDD</PDB_ID>
      <Resolution>2.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2GDD</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Human beta II tryptase with inhibitor CRA-27592</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Human Beta-Tryptase Complexed with a Synthetic Inhibitor with a Tropanylamide Scaffold</PDB_Title>
      <PDB_ID>3V7T</PDB_ID>
      <Resolution>2.09</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3V7T</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand></ASD_Ligand>
      <PubMed_Title>A beta-tryptase inhibitor with a tropanylamide scaffold to improve in vitro  stability and to lower hERG  channel binding affinity</PubMed_Title>
      <Author>Liang, G., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2012)22:1606-1610</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22264487?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN BETA-TRYPTASE: A RING-LIKE TETRAMER WITH ACTIVE SITES FACING A CENTRAL PORE</PDB_Title>
      <PDB_ID>1A0L</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1A0L</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Human beta-tryptase is a ring-like tetramer with active sites facing a central pore.</PubMed_Title>
      <Author>Pereira, P.J., et al.</Author>
      <Journal>Nature(1998)392:306-311</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9521329?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>human beta tryptase II complexed with activated ketone inhibitor CRA-29382</PDB_Title>
      <PDB_ID>2FXR</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2FXR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure-guided design of Peptide-based tryptase inhibitors.</PubMed_Title>
      <Author>McGrath, M.E., et al.</Author>
      <Journal>Biochemistry(2006)45:5964-5973</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16681368?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human beta tryptase II with inhibitor CRA-28427</PDB_Title>
      <PDB_ID>2FS9</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2FS9</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure-guided design of Peptide-based tryptase inhibitors.</PubMed_Title>
      <Author>McGrath, M.E., et al.</Author>
      <Journal>Biochemistry(2006)45:5964-5973</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16681368?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human tryptase with 2-amino benzimidazole</PDB_Title>
      <PDB_ID>2FPZ</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2FPZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure-guided design of Peptide-based tryptase inhibitors.</PubMed_Title>
      <Author>McGrath, M.E., et al.</Author>
      <Journal>Biochemistry(2006)45:5964-5973</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16681368?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Reference>A β-tryptase inhibitor with a tropanylamide scaffold to improve in vitro stability and to lower hERG channel binding affinity.</Site_Reference>
      <Site_Type>Allosteric competitive model</Site_Type>
      <PDB_ID>3V7T</PDB_ID>
      <PubMed_ID>22264487</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>3.4.21.59</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/4/21/59.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD11260001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2014-04-17</Create_Date>
</Organism_Record>